{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Celularity Inc."},"Symbol":{"label":"Symbol","value":"CELUW"},"Address":{"label":"Address","value":"170 PARK AVENUE, FLORHAM PARK, New Jersey, 07932, United States"},"Phone":{"label":"Phone","value":"+1 908 768-2170"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.celularity.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ramji Krishnan","title":"Chief Technology Officer"},{"name":"Robert Joseph Hariri Gordon","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}